Feds sue pharmacy gatekeepers over high insulin costs
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though prescribed for the past 100 years, only three companies supply insulin in the U.S. and much of that is higher-cost branded versions, despite the increasing availability of lower-price biologic options.
Express Scripts files suit against FTC, demands retraction of report on PBM industry These PBMs value high rebates from ...
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent FTC report ...
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the ...
Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...
As the FTC has increasingly prodded PBMs over their role in high drug costs, Express Scripts is fighting back by launching a ...
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback